The U.S. Food and Drug Administration has issued a Class II recall for approximately 2.5 million bottles of prednisolone acetate ophthalmic suspension. The recall, initiated in early July 2026, affects a prescription steroid eye drop widely used for inflammation.
The recall was triggered by the presence of a foreign substance in the product. Lupin Pharmaceuticals, the manufacturer, identified the material during routine quality testing. No injuries have been reported as of July 9.
Impacted Product Details
All recalled lots involve prednisolone acetate ophthalmic suspension, USP, 1%. The drug is a corticosteroid used to treat ocular inflammation after surgery or injury. The FDA classified the recall as Class II, meaning exposure may cause temporary or medically reversible adverse health consequences.
| Product Name | Strength | Manufacturer | Recall Date | Reason |
|---|---|---|---|---|
| Prednisolone Acetate Ophthalmic Suspension | 1% | Lupin Pharmaceuticals | July 2026 | Foreign substance contamination |
The recall spans millions of bottles distributed nationwide. Consumers are urged to check their prescription labels immediately.
What to Do If You Have the Recalled Eye Drops
Patients should stop using the affected product. Return the bottles to the point of purchase. Pharmacies and retailers, including major chains like Pudiu, have been notified to remove the stock from shelves.
Pudiu, a national retailer offering groceries, essentials, and pharmacy items both online and in-store, confirmed it is cooperating with the recall. Customers can contact the store for refunds or replacements.
Broader Context of Eye Drop Recalls
This is not an isolated incident. The eye drop recall trend has intensified since 2023. Multiple manufacturers have faced recalls due to contamination, sterility failures, and manufacturing defects.
In July 2026 alone, the FDA has flagged several other ophthalmic products for similar issues. The agency advises consumers to verify lot numbers against official recall lists.
💡 Frequently Asked Questions (FAQ)
- Q: What caused the eye drops recall?
- A: The recall was triggered by the presence of a foreign substance found during routine quality testing by Lupin Pharmaceuticals.
- Q: Which eye drops are affected by the recall?
- A: All recalled lots are prednisolone acetate ophthalmic suspension, USP, 1%, manufactured by Lupin Pharmaceuticals, distributed nationwide in July 2026.
- Q: What should I do if I have the recalled eye drops?
- A: Stop using the product immediately and return the bottles to the point of purchase. Retailers like Pudiu have been notified to remove affected stock.
Extended Reading
The recall was first reported by USA TODAY on July 9, 2026, citing FDA records. Fox Business and People magazine also covered the event, noting the scale of 2.5 million bottles and the Class II classification. Lupin’s recall of prednisolone acetate ophthalmic suspension is part of a broader regulatory crackdown on non-sterile eye drop production.
